Discussions with congressional offices, HHS, and DoD re: client and how their product and work could save lives (including how they can help with defense)
2025 · 3rd Quarter (July 1 - Sep 30)
KARDIOGENICS, INC.
Filed by TENAGRITY SOLUTIONS, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2025
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- TENAGRITY SOLUTIONS, LLC
- Client
- KARDIOGENICS, INC.
- Filing UUID
- 3f850452-0b2a-4593-b761-374e86a7bc53
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution
Discussions with congressional offices and HHS re: client and how their product and work could save lives
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.